No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs900610 |
chr12:31816623-31816624 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs145153340 |
chr12:31816673-31816674 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs11051520 |
chr12:31816681-31816682 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs576522367 |
chr12:31816709-31816710 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs539070372 |
chr12:31816750-31816751 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs900609 |
chr12:31816767-31816768 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs77970904 |
chr12:31816770-31816771 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs554567149 |
chr12:31816810-31816811 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs73303825 |
chr12:31816852-31816853 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs149139606 |
chr12:31816910-31816911 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs146546807 |
chr12:31816966-31816967 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs574890469 |
chr12:31816967-31816968 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs544108389 |
chr12:31817028-31817029 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs563858899 |
chr12:31817043-31817044 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs188468738 |
chr12:31817052-31817053 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs551006507 |
chr12:31817085-31817086 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs541576491 |
chr12:31817141-31817142 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs552962355 |
chr12:31817148-31817149 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs527393391 |
chr12:31817158-31817159 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs4931536 |
chr12:31817163-31817164 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|